Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes (Q38339089)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes (English)

1 reference

Europe PubMed Central

2 September 2017

Plasmodium falciparum

0 references

0 references

1 reference

based on heuristic

inferred from title

7

object named as

Mats Wahlgren

1 reference

Europe PubMed Central

2 September 2017

author name string

Qijun Chen

1

1 reference

Europe PubMed Central

2 September 2017

Fredrik Pettersson

2

1 reference

Europe PubMed Central

2 September 2017

Anna M Vogt

3

1 reference

Europe PubMed Central

2 September 2017

Berit Schmidt

4

1 reference

Europe PubMed Central

2 September 2017

Sanjay Ahuja

5

1 reference

Europe PubMed Central

2 September 2017

Peter Liljeström

6

1 reference

Europe PubMed Central

2 September 2017

language of work or name

0 references

publication date

1 July 2004

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

22

1 reference

Europe PubMed Central

2 September 2017

21-22

1 reference

Europe PubMed Central

2 September 2017

2701-2712

1 reference

Europe PubMed Central

2 September 2017

Malaria pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Autoagglutination of malaria-infected red blood cells and malaria severity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Plasmodium falciparum infections are associated with agglutinating antibodies to parasite-infected erythrocyte surface antigens among healthy Kenyan children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Plasmodium falciparum-infected erythrocytes form spontaneous erythrocyte rosettes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Glutathione S-transferases and related proteins from pathogenic human parasites behave as immunomodulatory factors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

The 3D7var5.2 (var COMMON) type var gene family is commonly expressed in non-placental Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Src-family kinase signaling modulates the adhesion of Plasmodium falciparum on human microvascular endothelium under flow

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Are trials in New World monkeys on the critical path for blood-stage malaria vaccine development?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Enhancing immune responses using suicidal DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

Receptor-specific adhesion and clinical disease in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.015

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.02.015

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38339089&oldid=1754566297"